Literature DB >> 12827274

Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues.

Michael J Gait1.   

Abstract

Improving the delivery of synthetic oligonucleotides and their analogues into cells is an important goal in the full development of antisense technology for control of gene expression in cell culture and in vivo. This review describes the harnessing of certain peptides, either as noncovalent complexes or as covalent conjugates, to enhance the delivery of antisense oligonucleotides into cells and/or to affect their cell localization. Phosphodiester and phosphorothioate oligonucleotides are included as well as peptide nucleic acids (PNAs), analogues of oligonucleotides where the negatively charged phosphate backbone is replaced by a neutral amide linkage. This review contains a critical evaluation of claims for certain peptide-oligonucleotide conjugates to translocate into cultured cells by a non-energy-dependent nonendosomal route. In addition, the available evidence for the utility of stable versus nonstable linkages between peptide and oligonucleotide or PNA is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827274     DOI: 10.1007/s00018-003-3044-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  24 in total

Review 1.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

2.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

3.  Selective glutaraldehyde-mediated coupling of proteins to the 3'-adenine terminus of polymerase chain reaction products.

Authors:  John G Bruno; Randy Crowell
Journal:  J Biomol Tech       Date:  2008-07

4.  Taking charge of siRNA delivery.

Authors:  Anastasia Khvorova; Maire F Osborn; Matthew R Hassler
Journal:  Nat Biotechnol       Date:  2014-12       Impact factor: 54.908

Review 5.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

6.  Extension of the PNA world by functionalized PNA monomers eligible candidates for inverse Diels Alder Click Chemistry.

Authors:  Manfred Wiessler; Waldemar Waldeck; Ruediger Pipkorn; Christian Kliem; Peter Lorenz; Heinz Fleischhacker; Manuel Hafner; Klaus Braun
Journal:  Int J Med Sci       Date:  2010-06-27       Impact factor: 3.738

7.  Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers.

Authors:  Meredith F Ross; Aleksandra Filipovska; Robin A J Smith; Michael J Gait; Michael P Murphy
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

8.  Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicing.

Authors:  Andrew M Siwkowski; Leila Malik; Christine C Esau; Martin A Maier; Edward V Wancewicz; Klaus Albertshofer; Brett P Monia; C Frank Bennett; Anne B Eldrup
Journal:  Nucleic Acids Res       Date:  2004-05-17       Impact factor: 16.971

Review 9.  Prospects for antisense peptide nucleic acid (PNA) therapies for HIV.

Authors:  Virendra N Pandey; Alok Upadhyay; Binay Chaubey
Journal:  Expert Opin Biol Ther       Date:  2009-08       Impact factor: 4.388

10.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.